Abstract 1616: Characterizing differences in checkpoint inhibitor biomarkers in a real-world cohort of stage III and IV non-small cell lung cancer patients

Authors: Yinjie Gao, Michelle M. Stein, Prerna Jain, Denise Lau, Kimberly L. Blackwell, Aly A. Khan

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-1616

Source: Full article


Abstract

Abstract